Hormone Receptor Positive Breast Adenocarcinoma

Explore clinical trials studying Hormone Receptor Positive Breast Adenocarcinoma. Study availability and eligibility vary by location and protocol.

4 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Hormone Receptor Positive Breast Adenocarcinoma trial results

Recruiting

NCT07020117

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations: City of Hope Duarte, California, United States

Hoag Memorial Hospital Presbyterian Irvine, California, United States

Biogenix Molecular, LLC Miami, Florida, United States

Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States

Recruiting

NCT06805812

Conditions: Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations: Centro di Riferimento Oncologico IRCCS Aviano, Italy

Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy

Humanitas Istituto Clinico Catanese Catania, Italy

ASST Lariana - Ospedale Sant'Anna Como, Italy

View all 24 locations

Completed

NCT06745804

Conditions: Hormone Receptor Positive Breast Adenocarcinoma, Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer
Locations: UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States

Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States

University of Iowa Iowa City, Iowa, United States

University of Michigan Medicine Ann Arbor, Michigan, United States

Completed

NCT04481113

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, +24 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States